Pregnancy & Medications

Essential Reads: The Impact of Prenatal Lithium Exposure on Offspring Cognitive Functioning

This clinical cohort study showed no impact of prenatal lithium exposure on cognitive functioning in children 6 to 14 years of age.

By |2021-10-20T10:21:06-04:00October 20th, 2021|Essential Reads, Mood Stabilizers, Neurodevelopmental Disorders, Pregnancy & Medications|Comments Off on Essential Reads: The Impact of Prenatal Lithium Exposure on Offspring Cognitive Functioning

Prospective Data on the Use of Newer Antipsychotics During Pregnancy: No Increase in Risk of Malformations

The most recent publication from the National Pregnancy Registry focuses on overall risk of malformations associated with the class of antipsychotic medications.

By |2021-09-09T15:55:20-04:00September 7th, 2021|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Prospective Data on the Use of Newer Antipsychotics During Pregnancy: No Increase in Risk of Malformations

Essential Reads: Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antiepileptic Drugs

There is a growing body of literature to indicate that exposure to certain antiepileptic drugs, most notably valproic acid (VPA, Depakote) during critical periods of development may be associated with long-lasting neurodevelopmental deficits.

By |2025-06-26T09:07:34-04:00September 1st, 2021|Anti-Epileptic Drugs, Essential Reads, Neurodevelopmental Disorders, Pregnancy & Medications|Comments Off on Essential Reads: Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antiepileptic Drugs

Prevalence of ADHD and Autism Spectrum Disorders in Children with Prenatal Exposure to Antipsychotic Medications

The findings of this study do not suggest that prenatal antipsychotics exposure is associated with increased risk for ADHD, ASD, small for gestational age, or preterm birth.

By |2024-04-14T16:15:58-04:00August 31st, 2021|Antipsychotic Medications, Pregnancy & Medications|Comments Off on Prevalence of ADHD and Autism Spectrum Disorders in Children with Prenatal Exposure to Antipsychotic Medications

Depression During Pregnancy Affect Infant’s Brain Anatomy, But No Change with Prenatal Exposure to SSRIs

Infants exposed to maternal depression during pregnancy had significantly larger subcortical grey matter volumes and smaller midbrain volumes.

By |2024-03-24T11:59:31-04:00June 22nd, 2021|Depressive Disorders, Pregnancy & Medications, Psychiatric Disorders During Pregnancy|Comments Off on Depression During Pregnancy Affect Infant’s Brain Anatomy, But No Change with Prenatal Exposure to SSRIs

Caffeine and Pregnancy: How Much is Safe?

Many women ask about the safety of drinking caffeinated beverages during pregnancy. A recent study looked at this question, analyzing data from the NICHD Fetal Growth Studies–Singletons, which included a group of 2,055 nonsmoking women at low risk for fetal growth problems.  Caffeine consumption was evaluated using plasma concentrations of caffeine and paraxanthine (a metabolite of caffeine) and self-reported caffeinated beverage consumption at 10 to 13 weeks gestation.

By |2021-04-23T12:21:43-04:00April 20th, 2021|Pregnancy & Medications, Psychiatric Disorders During Pregnancy|Comments Off on Caffeine and Pregnancy: How Much is Safe?
Go to Top